Analysis of Revascularization in Ischemic Stroke With EmboTrap

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 228 participants.

Also called NCT02488915

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 228 participants (enrolled count) (from the registry)
Sponsor
Neuravi Inc. (from the registry)
Registry
  • NCT NCT02488915
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Belgium, Germany, Ireland (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02488915. Allocation not applicable; no masking; primary purpose treatment. Start 2015-11 (actual); primary completion 2017-05 (actual). Results posted on 2018-07-13.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Analysis of Revascularization in Ischemic Stroke With EmboTrap
Acronym
ARISEII
Condition
Stroke
Condition
Ischemia
Intervention (Device)
EmboTrap® Revascularization Device
Lead sponsor
Neuravi Inc. (class: industry)

Record details

Record id
cardio:ct-nct02488915
Content hash
bdc9c2e1b125004199f208c83e9658dab113b06f644c4fd893f952af7da0c36a